Is wegovy going to be cheaper?

What factors might influence the cost of Wegovy

The cost of Wegovy, a prescription medication used to treat type 2 diabetes and obesity, can be influenced by several factors [1]. These include the manufacturer's pricing strategy, market demand, competition from other weight loss medications, insurance coverage, and the availability of discounts or financial assistance programs.

Comparison to other weight loss medications

Wegovy's cost will likely be compared to other weight loss medications on the market, such as Saxenda and Contrave. According to DrugPatentWatch.com, Saxenda's cost has been steadily decreasing since its patent expiry in 2022, and Contrave's cost has also been influenced by patent expiry [2].

When does the exclusivity expire?

The exclusivity period for Wegovy, which is currently protected by a patent, is set to expire in 2030. This may lead to the entry of generic or biosimilar versions of the medication, which could potentially reduce prices [3].

How might insurance coverage affect the cost?

Insurance coverage for Wegovy may vary depending on the provider and the patient's policy. In the US, some insurance plans may cover the medication, while others may not. The cost of the medication may be lower for patients with insurance coverage.

Pricing for similar medications in the UK

In the UK, prescription medications like Wegovy are typically priced significantly lower than in the US. A similar weight loss medication, semaglutide, is available in the UK for approximately £150-£200 per month. If the cost of Wegovy in the US is comparable to semaglutide in the UK, it may be significantly more expensive.

Can biosimilars enter the market before patent expiry?

It is possible that biosimilar versions of Wegovy could enter the market before the patent expiry date. Biosimilar manufacturers would need to meet strict regulatory requirements to demonstrate the safety and efficacy of their products before they can be approved for sale.

Sources:

[1] DrugPatentWatch.com. (2023). Wegovy (semaglutide) patent information. Retrieved from https://drugpatentwatch.com/patent/US10912361

[2] DrugPatentWatch.com. (2022). Saxenda (liraglutide) patent information. Retrieved from https://drugpatentwatch.com/patent/US8440305

[3] DrugPatentWatch.com. (2022). Wegovy (semaglutide) patent information. Retrieved from https://drugpatentwatch.com/patent/US10912361